Rhabdomyosarcoma Clinical Trials 2022

Browse 59 Rhabdomyosarcoma Medical Studies Across 172 Cities

4 Phase 3 Trial · 1720 Rhabdomyosarcoma Clinics

Reviewed by Michael Gill, B. Sc.
25 Rhabdomyosarcoma Clinical Trials Near Me
Houston, TX
Birmingham, AL
Saint Louis, MO
Indianapolis, IN
More Trial Locations
An interactive map to display trial locations for Houston Methodist Hospital, Children's Hospital of Alabama, Washington University School of Medicine, Riley Hospital for Children, and 199 more locations.
Most Popular References for Rhabdomyosarcoma Clinical Trials
Frequency
Citation
Top Hospitals for Rhabdomyosarcoma Clinical Trials
Location
Active Rhabdomyosarcoma Clinical Trials
All Time Trials for Rhabdomyosarcoma
First Recorded Rhabdomyosarcoma Trial
Trials
Children's Hospital Colorado, Aurora, Colorado
17
30
1999
Children's Hospital Los Angeles, Los Angeles, California
17
40
1997
Top Treatments for Rhabdomyosarcoma Clinical Trials
Treatment Name
Active Rhabdomyosarcoma Clinical Trials
All Time Trials for Rhabdomyosarcoma
First Recorded Rhabdomyosarcoma Trial
Trials
Top Cities for Rhabdomyosarcoma Clinical Trials
City
Active Rhabdomyosarcoma Clinical Trials
Top Active Site for Rhabdomyosarcoma Clinical Trials
Trial List
New York, New York
46
Memorial Sloan Kettering Cancer Center
Houston, Texas
37
M D Anderson Cancer Center
Most Recent Rhabdomyosarcoma Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
9/29/2022
Phase 1 & 2
Phase 3 Rhabdomyosarcoma Clinical Trials
Pediatric Rhabdomyosarcoma Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
9/29/2022
Phase 1 & 2
Senior Friendly Rhabdomyosarcoma Clinical Trials
Recently Completed Studies with FDA Approved Treatments for Rhabdomyosarcoma
Treatment
Year
Mechanism of Action
Sponsor
Active Rhabdomyosarcoma Clinical Trials
Nivolumab
2021
Nivolumab
Bristol-Myers Squibb
2
Eribulin mesylate
2018
Eribulin
Eisai Inc.
0
TAA-Specific CTLs
2015
Baylor College of Medicine
0

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 25th, 2021

Last Reviewed: August 13th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.